India's Caplin Point jumps as Brazil regulator's inspection at facility ends

Caplin Point Laboratories

19/08/2024 07:47

** Shares of Caplin Point Laboratories  CAPL.NS  jump ~12%
to 1,771 rupees, its highest since May 2014 
    ** Brazil's health regulator Anvisa concluded inspection of
co's manufacturing facility in Tamil Nadu, with zero
observations 
    ** The facility includes injectables and ophthalmic
manufacturing
    ** Brazil is an important part of our expansion plans in
Latin America and this clearance opens the door to the largest
market in that geography, said Caplin Point Laboratories
Chairman C.C. Paarthipan
    ** Stock eyes busiest trading session since Sept. 2021,
volumes at 16.8x the 30-day avg 
    ** Including session's gains, stock up ~31% YTD 

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))